The management of myelofibrosis: A British Society for Haematology Guideline-Reference-Cited by-同舟云学术

The management of myelofibrosis: A British Society for Haematology Guideline

Published:2023-12 Issue:1 Volume:204 Page:136-150
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

McLornan Donal P.¹^ORCID,Psaila Bethan²³^ORCID,Ewing Joanne⁴,Innes Andrew⁵^ORCID,Arami Siamak⁶,Brady Jessica⁷,Butt Nauman M.⁸,Cargo Catherine⁹,Cross Nicholas C. P.¹⁰^ORCID,Francis Sebastian¹¹,Frewin Rebecca¹²,Garg Mamta¹³,Godfrey Anna L.¹⁴,Green Anna¹⁵,Khan Alesia⁹^ORCID,Knapper Steve¹⁶,Lambert Jonathan¹,McGregor Andrew¹⁷,McMullin Mary Frances¹⁸^ORCID,Nangalia Jyoti¹⁹,Neelakantan Pratap²⁰,Woodley Claire²¹,Mead Adam²³^ORCID,Somervaille Tim C. P.²²,Harrison Claire N.²¹^ORCID,

Affiliation:

1. Department of Haematology University College London Hospitals London UK

2. MRC Weatherall Institute of Molecular Medicine University of Oxford Oxford UK

3. Department of Haematology, Churchill Hospital Oxford University NHS Trust Oxford UK

4. Department of Haematology University Hospitals Birmingham Trust London UK

5. Department of Haematology Imperial College London UK

6. Department of Haematology London Northwest Healthcare University NHS Trust London UK

7. Department of Clinical Oncology Guy's and St. Thomas' NHS Foundation Trust London UK

8. Department of Haematology The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool UK

9. Department of Haematology Leeds Teaching Hospitals NHS Foundation Trust Leeds UK

10. Faculty of Medicine University of Southampton Southampton UK

11. Department of Haematology Sheffield Teaching Hospital NHS Foundation Trust Sheffield UK

12. Department of Haematology Gloucestershire Hospitals NHS Foundation Trust Gloucester UK

13. Department of Haematology University Hospitals Leicester NHS Trust Leicester UK

14. Haematopathology & Oncology Diagnostics Service, Department of Haematology Cambridge University Hospitals NHS Foundation Trust Cambridge UK

15. Department of Histopathology Guy's and St. Thomas' NHS Foundation Trust London UK

16. Department of Haematology Cardiff University Cardiff UK

17. Department of Haematology Freeman Hospital Newcastle UK

18. Centre for Medical Education Queen's University Belfast UK

19. Wellcome Sanger Institute University of Cambridge Cambridge UK

20. Department of Haematology Royal Berkshire NHS Foundation Trust London UK

21. Department of Haematology Guy's and St. Thomas' NHS Foundation Trust London UK

22. Cancer Research UK Manchester Institute & The Christie NHS Foundation Trust Manchester UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19186

Reference84 articles.

1. Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012

2. How common are myeloproliferative neoplasms? A systematic review and meta-analysis

3. A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

4. JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

5. Early intervention in myelofibrosis and impact on outcomes: A pooled analysis of the COMFORT‐I and COMFORT‐II studies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis;Life;2024-04-17

2. Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report;Oncology Letters;2024-03-22

3. Evidence creation for myelofibrosis: Challenges and opportunities;British Journal of Haematology;2023-12-11